Heart Disease Trial, Recruiting NCT06009809 Sponsor: Fondazione Policlinico Universitario Agostino Gemelli IRCCS Condition: Heart Disease
Back to Heart Disease

Heart Disease Trial, Recruiting

NCT06009809
Recruiting Not Applicable

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

  • Adults over 18 years of age
  • People who are able to give written consent to participate
  • People who are scheduled to have heart surgery using a heart-lung bypass machine
  • People whose heart failure symptoms fall into a mild-to-moderate category (rated as Class I, II, or III on a standard medical scale)
  • People whose blood test shows that their kidneys are working within a normal range before surgery (creatinine level below 1.2 mg/dl)

Who may not be able to join:

  • People who cannot safely have a specialised ultrasound probe placed down the throat, for example due to conditions or past surgery affecting the oesophagus or stomach
  • People with a history of blood vessel diseases outside of the heart's own arteries
  • People who have atrial fibrillation (an irregular heart rhythm condition)
  • People whose blood test shows reduced kidney function before surgery (creatinine level above 1.2 mg/dl)
  • People whose heart failure symptoms are in the most severe category (rated as Class IV on a standard medical scale)
  • People who require emergency heart surgery

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.
Last synced 7 July 2026
This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Principal Investigator: Cavaliere Franco, M.D., Fondazione Policlinico Agostino Gemelli IRRCS

Phone: +390630154848

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Trial details

Status
Recruiting
Phase
Not Applicable
Registry
ClinicalTrials.gov
Start date
15 February 2022
Est. completion
31 December 2025

Where this trial is recruiting

🇮🇹 Italy

Primary endpoints

Comparison of right renal artery mean blood velocities before and during cardiopulmonary by-pass (CPB); Comparison of right renal artery mean blood velocities before and during cardiopulmonary by-pass (CPB); Comparison of right renal artery mean blood velocities before and during cardiopulmonary by-pass (CPB); Comparison of right renal artery mean blood velocities before and during cardiopulmonary by-pass (CPB); Comparison of right renal artery mean blood velocities before and during cardiopulmonary by-pass (CPB)

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 7 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov